This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Big Stocks to Trade for Gains

Stocks in this article: ITUB INTC PFE LLY GE

Pfizer

Pfizer (PFE) is another name that's showing relative strength right now. Shares of Pfizer made a bottom back on Aug. 8 but didn't retest it on Oct. 3 when the market made a new low, which indicated that buyers were still in control of this stock when the S&P was teetering. Since August, Pfizer has been locked in an uptrending channel, bouncing between the dashed trend line support and resistance lines in the chart above. Now shares are testing a double breakout.

It's a double breakout because not only is Pfizer testing a push through its dashed trend line resistance level, the stock is also breaking out above it's previous horizontal resistance level at $20.20. The key to whether this stock is tradable now becomes confirmation -- yesterday's breakout is still too small to be considered statistically significant.

Confirmation in this stock comes on an open above $20.20 that pushes through yesterday's highs. When that condition is met, it's a safe bet that the excess of supply of Pfizer shares above that level has been absorbed by buyers. Afterwards, I'd recommend keeping a protective stop just below $20.

If this breakout isn't confirmed, Pfizer is likely to make its way back down to trend line support.

Pfizer, one of the highest-yielding drug stocks, shows up on a list of 10 Top Stock Picks From Morgan Stanley.

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs